Therapeutic potential of somatic cell nuclear transfer for degenerative disease caused by mitochondrial DNA mutations

Induced pluripotent stem cells (iPSCs) hold much promise in the quest for personalised cell therapies. However, the persistence of founder cell mitochondrial DNA (mtDNA) mutations limits the potential of iPSCs in the development of treatments for mtDNA disease. This problem may be overcome by using...

Descripción completa

Detalles Bibliográficos
Autores principales: Greggains, Gareth D., Lister, Lisa M., Tuppen, Helen A. L., Zhang, Qi, Needham, Louise H., Prathalingam, Nilendran, Hyslop, Louise A., Craven, Lyndsey, Polanski, Zbigniew, Murdoch, Alison P., Turnbull, Douglass M., Herbert, Mary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379195/
https://www.ncbi.nlm.nih.gov/pubmed/24457623
http://dx.doi.org/10.1038/srep03844

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379195/
https://www.ncbi.nlm.nih.gov/pubmed/24457623
http://dx.doi.org/10.1038/srep03844

Ejemplares similares